Product Images Sacubitril And Valsartan
View Photos of Packaging, Labels & Appearance
- 60 bottle label - sacubitrilvalsartan 24 26
- figure 7 - sacubitrilvalsartan 7 figure
- 60 bottle label - sacubitrilvalsartan 97103
- sacubitrilvalsartan-fig-2 - sacubitrilvalsartan fig 2
- Figure 1 - sacubitrilvalsartan fig1
- Figure 3 - sacubitrilvalsartan fig3
- Figure 4 - sacubitrilvalsartan fig4
- figure 6 - sacubitrilvalsartan figur6
- figure 5 - sacubitrilvalsartan figure5
- 60 tablets bottle label - sacubitrilvalsartan mg 49 51
- Structure - sacubitrilvalsartan str
Product Label Images
The following 11 images provide visual information about the product associated with Sacubitril And Valsartan NDC 62332-557 by Alembic Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
60 bottle label - sacubitrilvalsartan 24 26
figure 7 - sacubitrilvalsartan 7 figure
60 bottle label - sacubitrilvalsartan 97103
This text provides information about a medication called Sacubitril and Valsartan Tablets. Each tablet contains 97 mg of sacubitril and 103 mg of valsartan. The usual dosage is not specified. The medicine should be stored at room temperature, away from moisture. The manufacturer is Alembic Pharmaceuticals Limited. The text also includes details about the dosage, manufacturing locations, and other relevant information.*
sacubitrilvalsartan-fig-2 - sacubitrilvalsartan fig 2
Figure 1 - sacubitrilvalsartan fig1
This is a list of coadministered drugs with their geometric mean ratio and 90% confidence interval, along with a statement indicating the change relative to the reference drug. The list includes drugs such as Furosemide, Warfarin, Digoxin, Carvedilol, Levonorgestrel, Ethinyl estradiol, Amlodipine, Hertz, Metformin, Atorvastatin, and Sildenafil.*
Figure 3 - sacubitrilvalsartan fig3
This is a detailed analysis of the time to first occurrence of cardiovascular death, heart failure hospitalizations, and occurrence of cardiovascular death in patients enrolled in the PARADIGM-HF study. The data shown includes hazard ratios and confidence intervals over different time intervals since randomization in days. The comparison is made between the effects of Enalapril, Sacubitril, and Valsartan on the mentioned occurrences. The graphs illustrate the trends and outcomes for each of the mentioned events.*
Figure 4 - sacubitrilvalsartan fig4
This data table provides information on various subgroups within a study population, including demographic details, medical history, and treatment outcomes related to heart failure. The table displays percentages of the total population within each subgroup, along with specific data points such as age, gender, weight, race, region, NYHA class, estimated GFR, blood pressure, ejection fraction, atrial fibrillation, NT-proBNP levels, hypertension status, prior use of medications like ACE inhibitors and ARBs, prior hospitalizations for heart failure, time since diagnosis, cause of heart failure, and usage of specific medications like Sacubitril/Valsartan and Enalapril. Additionally, hazard ratios comparing the efficacy of Sacubitril/Valsartan versus Enalapril in heart failure treatment are provided in the table.*
figure 6 - sacubitrilvalsartan figur6
figure 5 - sacubitrilvalsartan figure5
This information seems to be related to a study or trial involving a medication called Sacubitril and Valsartan in patients with heart failure. The data is possibly showing the number of events or patients involved in the study over a period of time since randomization. The study may have looked at total heart failure hospitalizations and cardiovascular deaths in patients using this medication.*
60 tablets bottle label - sacubitrilvalsartan mg 49 51
Structure - sacubitrilvalsartan str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
